Nepean Pain Management is the only multidisciplinary pain management service in Australia to be offering Scrambler Therapy.
Scrambler Therapy is a new non-invasive treatment which benefits patients troubled with nerve/neuropathic pain.
Both Professor Raj Sundaraj and Dr Shona Sundaraj are the only doctors in Australia to be certified as trainers in Scrambler Therapy by Professor Giuseppe Marineo, the inventor of the Scrambler Therapy device.
The treatment is carried out by placing electrodes onto non-painful areas which surround the region of pain. It does not involve sedation or hospital stay. Scrambler Therapy takes place in the outpatient setting over a course of around 10 sessions. This is an established not experimental form of treatment for nerve / neuropathic pain which is TGA registered (ARTG: 30115) for Nepean Pain Management.
Examples of nerve pain include:
Scrambler Therapy uses electrodes which are similar to ECG electrodes. Electrodes are placed on the skin away from the site of pain. When the electrode is turned on, there is a humming or buzzing sensation felt.
The stimulation should not be painful. If it is painful, electrode placement is modified and treatment is restarted.
The Scrambler Therapy device will constantly vary its pre-set stimulation algorithm. Treatment lasts for 30-40 minutes.
In chronic neuropathic pain:
Scrambler Therapy is given as a course of sessions on consecutive weekdays (Monday-Friday). There will be an average of ten sessions per therapy course.
Nerve pain should approach 0/10 when the electrodes are applied. It is likely that the pain will return but to a lesser intensity and in a smaller area than prior to treatment.
We anticipate pain relief of up to 70-80% for patients with nerve pain. How long pain stays resolved is different for each person - it may last for 3 -12 months, or perhaps even longer.
Several international studies have been performed on the use of Scrambler Therapy with various conditions that cause pain. These have all reported no significant side effects by subjects during use.
Prior to your initial Scrambler Therapy session, we will ask you to complete a questionnaire. This is both for clinical and research purposes.
The data will be de-identified and used to publish our results on the effectiveness of Scrambler Therapy.
Scrambler Therapy is very new. Nepean Pain Management received approval from the Australian Government's Therapeutic Goods Administration for the importation of this medical device on the 20th March 2018. (ARTG: 30115)
As this therapy is so new, it is not currently covered by Medicare or private health insurance. Workers’ compensation insurers are starting to look at Scrambler Therapy as a helpful aid in return to work, and therefore have provided us with several patient approvals for this treatment.
Once our research data can be collated to provide a substantial evidence base, we hope to gain potential funding from Medicare, Department of Veteran’s Affairs and private health insurers.
You will be weaned off your anticonvulsant and high dose opioid medications. These interfere with sensation and can delay success. A plan will be given to you at your pre-Scrambler Therapy consultation.
People that cannot be treated with Scrambler Therapy include:
Professor Giuseppe Marineo is the inventor of the Scrambler device. He has a comprehensive list of international articles that have published studies on the device.
Visit the Clinical Trials page for Scrambler Therapy